These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31926310)

  • 1. PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis.
    Liu F; Wan L; Zou H; Pan Z; Zhou W; Lu X
    Int J Biochem Cell Biol; 2020 Mar; 120():105686. PubMed ID: 31926310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
    Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
    Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.
    Li F; Wang X; Zhang J; Jing X; Zhou J; Jiang Q; Cao L; Cai S; Miao J; Tong D; Shyy JY; Huang C
    Cell Death Dis; 2024 Jun; 15(6):427. PubMed ID: 38890303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 10. PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.
    Chen S; He Z; Peng T; Zhou F; Wang G; Qian K; Ju L; Xiao Y; Wang X
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34499617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
    Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
    Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.
    Zhao Z; Zhang M; Duan X; Chen Y; Li E; Luo L; Wu W; Peng Z; Qiu H; Zeng G
    Mol Cancer Res; 2018 Jun; 16(6):1013-1023. PubMed ID: 29545479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.
    Vindrieux D; Devailly G; Augert A; Le Calvé B; Ferrand M; Pigny P; Payen L; Lambeau G; Perrais M; Aubert S; Simonnet H; Dante R; Bernard D
    Oncotarget; 2014 Feb; 5(4):1004-13. PubMed ID: 24657971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
    Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
    Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling.
    Taguchi L; Miyakuni K; Morishita Y; Morikawa T; Fukayama M; Miyazono K; Ehata S
    Cancer Sci; 2019 Jun; 110(6):2063-2074. PubMed ID: 30972853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
    Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
    Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.